• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

China

starfield
China plant-based protein player Starfield raises $100m

Primavera Capital Group has led a USD 100m Series B for Starfield, a Chinese producer of plant-based meats.

  • Greater China
  • 13 January 2022
China sustainability start-up Bluepha raises $235m

Bluepha, a China-based synthetic biology company working on a range of biodegradable plastics, has raised a three-tranche Series B of CNY 1.5bn (USD 235m).

  • Greater China
  • 12 January 2022
Goldman, Sofina lead Series C for China CDMO Zhenge

Goldman Sachs Asset Management and Sofina have led a USD 100m Series C round for Zhenge Biotech, a Shanghai-based contract development and manufacturing organisation (CDMO).

  • Greater China
  • 12 January 2022
Fund focus: Eastern Bell targets digitalisation

As a supply chain specialist, Eastern Bell Capital claims to have a differentiated take on China industrial digitalisation. It has USD 800m in dry powder to prove this thesis

  • Greater China
  • 11 January 2022
pizza-slice-serve
FountainVest buys China QSR restaurant operator from EQT

FountainVest Partners has acquired China F&B Group (CFB), one of the master franchise operators for Papa John’s and Dairy Queen in mainland China, from EQT for an undisclosed sum.

  • Greater China
  • 10 January 2022
dna-genetics-01
China gene therapy start-up Cure Genetics raises $60m

Advantech Capital has led a USD 60m Series B for Suzhou-based biotech player Cure Genetics. Other investors include Oriza Holdings, Blue Ocean Private Equity, and Qiming Venture Partners.

  • Greater China
  • 10 January 2022
Singapore's Virtue Diagnostics closes $100m Series B

Singapore-based Virtue Diagnostics, a clinical testing equipment supplier for China and developing markets, has raised a USD 100m Series B round led by Sequoia Capital China and Morningside Ventures.

  • Southeast Asia
  • 10 January 2022
China's Ince raises $700m across two funds

Ince Capital, a Chinese venture capital firm established by J.P. Gan, formerly a managing partner at Qiming Venture Partners, has raised USD 700m for its second fund and for an accompanying vehicle aimed at later-stage opportunities.

  • Greater China
  • 07 January 2022
gaming-gamer
China AI gaming company Parametrix raises $100m

Chinese artificial intelligence (AI) gaming company Parametrix.ai has raised a USD 100m Series B round led by Sequoia Capital China. Existing investors 5Y Capital and Gaorong Capital re-upped.

  • Greater China
  • 06 January 2022
ritadose
AGIC exits healthcare business Ritedose to Novo Holdings

AGIC Capital, which specializes in cross-border deals along the China-Europe axis, has agreed to sell pharmaceutical manufacturing and packaging business Ritedose Corporation to Novo Holdings.

  • Greater China
  • 05 January 2022
imab-biotech-drug-healthcare
China CDMO Thousand Oaks raises $240m

Thousand Oaks Biopharmaceuticals, a China-based contract development and manufacturing organization (CDMO), has raised CNY 1.5bn (USD 240m) in funding led by Goldstone Investment - a private equity unit of CITIC Securities - and CDH Investments.

  • Greater China
  • 05 January 2022
Jafco closes latest Asia VC fund at $130m

Japanese venture capital firm Jafco has closed its latest Asia fund with USD 130m in commitments. It will focus on China, India, and Southeast Asia.

  • Southeast Asia
  • 05 January 2022
Eastern Bell raises $2b across US dollar, renminbi funds

Eastern Bell Capital has closed its second US dollar-denominated fund and its sixth renminbi-denominated fund with aggregate commitments of more than CNY 13bn (USD 2bn).

  • Greater China
  • 04 January 2022
China biotech player GenFleet raises $75m

GenFleet Therapeutics, a Chinese biotech developer focused on oncology and immunology, has secured a USD 75m Series C round led by Huagai Capital.

  • Greater China
  • 03 January 2022
artificial-intelligence-facial-recognition-4
China's SenseTime perseveres with IPO despite blacklisting

Chinese artificial intelligence (AI) technology developer SenseTime has relaunched its IPO on the same terms, albeit excluding US investors, after being placed on another blacklist by the US government.

  • Greater China
  • 22 December 2021
spv-floor
ADV backs Asia, North America flooring manufacturer

ADV Partners has acquired a significant minority interest in CFL Technologies, a flooring materials business with a presence in multiple locations in the US, China, and Vietnam.

  • Greater China
  • 17 December 2021
telemedicine-telehealth-s
2022 preview: Healthcare

Healthcare’s high-cost, rapidly digitizing profile will persist regardless of how COVID-19 plays out in the coming years. China appears set for consolidation, including in biotech

  • Greater China
  • 15 December 2021
2022 preview: China sustainability

Green-tech investment, from electric vehicles to renewable energy, is already in the ascendency as China ponders a carbon-neutral future. Momentum is expected to grow in 2022

  • Greater China
  • 15 December 2021
storm-cloudy-uncertainty-risk
2022 preview: China fundraising

Investors held fire on commitments to China managers amid uncertainty over regulatory reforms. Industry participants hope the government will provide clarity, but the fear LPs won’t hurry back

  • Greater China
  • 15 December 2021
money-rain
2022 preview: Macro & buyout

Will the bullish investment environment persist through 2022? Most Asia-based private equity players expect to remain busy, although they acknowledge a lack of visibility around macro and geopolitical risk

  • Buyouts
  • 15 December 2021
saas-software-enterprise
2022 preview: SaaS

Software-as-a-service continues to benefit from a digitalization push across multiple markets. Investors are looking for differentiation in a market characterized by high valuations and intense competition

  • Technology
  • 15 December 2021
fruit-fresh-supermarket
China supermarket chain T11 raises $100m

T11, a China-based, technology-enabled supermarket chain, has raised a $100 million Series B led by Alibaba Group. Other investors include Redview Capital and MSA Capital.

  • Greater China
  • 15 December 2021
richard-li-legend-capital
Q&A: Legend Capital's Richard Li

Richard Li, president of Legend Capital, on evolving US-China relations, the logic behind the recent wave of regulation, investing in line with government policy, and why LPs should get used to onshore exits

  • Greater China
  • 15 December 2021
money-coins-pile
2021 in review: Boom time

Cheap debt and a desire for assets that deliver technology-driven growth have propelled Asia private equity investment to new highs and supported a resurgence in exits. But fundraising still fails to convince

  • Greater China
  • 15 December 2021
31 32 33
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013